2. Opening of the Austrian Cochrane Branch - Marcus Muellner

2,177 views
2,092 views

Published on

Professor Marcus Müllner of the Austrian Agency for Health and Food Safety (AGES) presents "Does evidence-based decision making exist?" at the opening of the Austrian Cochrane Branch on December 14th, 2010 in Krems.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
2,177
On SlideShare
0
From Embeds
0
Number of Embeds
885
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide
  • Einsatz von Generika in dieser heiklen Indikation würde eine Unsicherheit für Arzt und Patienten und ein nicht einschätzbares Risiko der seltenen, aber gefährlichen Stentthrombose bedeuten
  • Einsatz von Generika in dieser heiklen Indikation würde eine Unsicherheit für Arzt und Patienten und ein nicht einschätzbares Risiko der seltenen, aber gefährlichen Stentthrombose bedeuten
  • (a) Contracts to ensure availability of vaccinations or (b) no action?
  • 2. Opening of the Austrian Cochrane Branch - Marcus Muellner

    1. 1. Does Evidence Based Decision Making exist? Examples from Austria and the EU Marcus Müllner Austrian Medicines & Medical Devices Agency (AGES PharmMed )
    2. 2. Is Evidence Based Decision Making possible? <ul><li>Are we wired to work with evidence? </li></ul>Yes, but … no, but … yes, but … no, but …
    3. 3. Is Evidence Based Decision Making possible? <ul><li>Do we have enough evidence? </li></ul>Can we ever have enough valid evidence?
    4. 4. Is Evidence Based Decision Making possible? <ul><li>Do we have enough evidence? </li></ul>Can we ever have enough valid evidence? <ul><li>Efficacy of homoeopathics? </li></ul><ul><li>Efficacy & effectiveness of generics </li></ul><ul><li>Safety of vaccinations … </li></ul>
    5. 5. Two stories (1a) USA 75% 30% in 2009 70% in 2010
    6. 6. Two stories (1b) <ul><li>Efficacy & effectiveness of generics </li></ul>„ Der unkontrollierte Einsatz von Generika … würde … ein nicht einschätzbares Risiko … bedeuten!
    7. 7. Two stories (1c) <ul><li>Efficacy & effectiveness of generics </li></ul>CMAJ 2005 Kesselheim JAMA 2008
    8. 8. Two stories (2) <ul><li>Efficacy of hyaluronic acid for osteoarthrosis </li></ul>CMAJ 2005
    9. 9. Is Evidence Based Decision Making possible? Theoretically yes
    10. 10. What do we need for (more) Evidence Based Decision Making? <ul><li>A typical example for public health … </li></ul><ul><li>Ensure availability of vaccinations </li></ul><ul><li>or </li></ul><ul><li>(b) no action? </li></ul>
    11. 11. What do we need for (more) Evidence Based Decision Making? <ul><li>We need … </li></ul><ul><li>The best evidence available </li></ul><ul><li>Those who know where to find and how to interprete it </li></ul><ul><li>Bridges and (transparent) leaps of faith to deal with uncertainty </li></ul><ul><li>Good and proactive communication </li></ul>
    12. 12. What do we need for (more) Evidence Based Decision Making? <ul><li>We need … </li></ul><ul><li>The best evidence available </li></ul><ul><li>Those who know where to find and how to interprete it </li></ul><ul><li>Bridges and (transparent) leaps of faith </li></ul><ul><li>Good and proactive communication </li></ul>
    13. 13. What do we need for (more) Evidence Based Decision Making? On bridges, (transparent) leaps of faith and good communication http://www.alpbach.org/fileadmin/user_upload/PDFs/Weitere_Veranstaltungen/Medizin_und_Ethik_2010/GIGERENZER_GERD.pdf
    14. 14. What do we need for (more) Evidence Based Decision Making? <ul><li>We need … </li></ul><ul><li>The best evidence available </li></ul><ul><li>Those who know where to find and how to interprete it </li></ul><ul><li>Bridges and (transparent) leaps of faith to deal with uncertainty </li></ul><ul><li>Good and proactive communication </li></ul>

    ×